AI is used in personalized medicine to analyze individual patient data, genetic information, and medical records to tailor treatments and interventions. It employs machine learning algorithms and predictive modeling to enable precision diagnosis, personalized treatment plans, and improved patient outcomes.
AI has the potential to revolutionize health care by streamlining workflows, enhancing diagnostics, and improving patient outcomes, but barriers such as data privacy, high costs, and regulatory challenges slow its adoption. This comprehensive review offers a roadmap to overcome these hurdles and unlock AI's full potential in medicine.
Researchers from KIIT and Chandragupt Institute of Management explore how machine learning transforms big data challenges into opportunities, enabling industries to harness vast data resources effectively.
A new study in JAMA led by Mass General Brigham researchers shows that AI can significantly speed up clinical trial enrollment. The AI-assisted screening tool doubled the enrollment rate for a heart failure trial compared to manual methods, reducing costs and accelerating patient access to treatments.
Scientists have developed EpiBERT, an AI model that predicts gene expression by decoding chromatin accessibility and regulatory grammar across human cell types.
Researchers have developed a noninvasive AI-driven method to accurately reconstruct heart muscle cell electrical activity, offering new possibilities for drug testing and personalized medicine.
Researchers introduce DeepProfile, a groundbreaking deep learning framework that deciphers gene expression data across 18 cancers, uncovering critical pathways linked to survival and treatment responses.
Researchers developed a machine learning technique to predict obesity risk by analyzing sociodemographic, lifestyle, and health factors. The study, which achieved 79% accuracy, identified significant predictors like age, sex, education, diet, and smoking habits, offering valuable insights for personalized obesity prevention.
A recent article in Nature Communications introduces a groundbreaking approach for continuous monitoring of nucleic acids using wearable technology. Leveraging tetrahedral nanostructure-based argonaute technology, the study presents a fully integrated wearable system capable of real-time monitoring of ultratrace nucleic acids, offering promising applications in disease surveillance and intervention, particularly for conditions like sepsis.
This study explores the synergies between artificial intelligence (AI) and electronic skin (e-skin) systems, envisioning a transformative impact on robotics and medicine. E-skins, equipped with diverse sensors, offer a wealth of health data, and the integration of advanced machine learning techniques promises to revolutionize data analysis, optimize hardware, and propel applications from prosthetics to personalized health diagnostics.
This paper explores how artificial intelligence (AI) is revolutionizing regenerative medicine by advancing drug discovery, disease modeling, predictive modeling, personalized medicine, tissue engineering, clinical trials, patient monitoring, patient education, and regulatory compliance.
Researchers introduce the e3-skin, a versatile electronic skin created using semisolid extrusion 3D printing. This innovative technology combines various sensors for biomolecular data, vital signs, and behavioral responses, making it a powerful tool for real-time health monitoring. Machine learning enhances its capabilities, particularly in predicting behavioral responses to factors like alcohol consumption.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.